Reduction of host cell mitochondrial activity as Mycobacterium leprae's strategy to evade host innate immunity.

Marcus Fernandes Oliveira, Rychelle Clayde Affonso Medeiros, Bruno Siqueira Mietto, Thyago Leal Calvo, Ana Paula Miranda Mendonça, Thabatta Leal Silveira Andrezo Rosa, Débora Santos da Silva, Karina Girardi do Carmo de Vasconcelos, Antonio Marcos Rodrigues Pereira, Cristiana Santos de Macedo, Geraldo Moura Batista Pereira, Marcia de Berrêdo Pinho Moreira, Maria Cristina Vidal Pessolani, Milton Ozório Moraes, F A Lara

Journal: Immunological reviews 2021;301(1):193-208

PMID: 33913182

Abstract

Leprosy is a much-feared incapacitating infectious disease caused by Mycobacterium leprae or M lepromatosis, annually affecting roughly 200,000 people worldwide. During host-pathogen interaction, M leprae subverts the immune response, leading to development of disease. Throughout the last few decades, the impact of energy metabolism on the control of intracellular pathogens and leukocytic differentiation has become more evident. Mitochondria play a key role in regulating newly-discovered immune signaling pathways by controlling redox metabolism and the flow of energy besides activating inflammasome, xenophagy, and apoptosis. Likewise, this organelle, whose origin is probably an alphaproteobacterium, directly controls the intracellular pathogens attempting to invade its niche, a feature conquered at the expense of billions of years of coevolution. In the present review, we discuss the role of reduced host cell mitochondrial activity during M leprae infection and the consequential fates of M leprae and host innate immunity. Conceivably, inhibition of mitochondrial energy metabolism emerges as an overlooked and novel mechanism developed by M leprae to evade xenophagy and the host immune response.

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Address: Laboratório de Bioquímica de Resposta ao Estresse, Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.; Laboratório de Microbiologia Celular, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.; Instituto de Ciências Biológicas, Universidade Federal de Juiz de Fora, Minas Gerais, Brazil.; Laboratório de Hanseníase, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.; Centro de Desenvolvimento Tecnológico em Saúde, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.